Assessing the Impact of Iron Deficiency Anemia Treatment on Type 2 Diabetic Complications

The study was aimed to evaluate the relationship between the iron deficiency anemia (IDA) and type
2 diabetes, to estimate the effect of the IDA on the level of glucose and glycated hemoglobin (Hb1Ac)
and to assess the ameliorating effect of IDA treatment on progression of diabetes and its
complications. This study included 125 male Fasting blood glucose (FBG), HbA1c, CBC, ferritin, iron,
and total iron binding capacity (TIBC) were assayed. The HbA1c and FBG levels were significantly
higher in groups III and IV compared to group I. The results revealed a significant decline in HbA1c
and FBG levels in group V compared to group IV. Negative significant correlations were observed
between iron and ferritin with HbA1c and FBG. Ferritin was the most reliable predictor of type 2
diabetes in patients with IDA. The best cut off value for ferritin was 31.56 ng/ml. Low iron level has a
crucial effect on glycemic status by increasing the level of FBG and HbA1c, IDA is strongly correlated
with type 2 diabetes and the iron supplementation for diabetic patients with IDA ameliorates the
progression of diabetes and its complications.